glp-1 drug tirzepatide Study flags need to monitor frailty risks with drugs for older adults FDA Says Shortage of GLP-1

As our earlier article showed, the possibilities range across any number of body systems, touching Alzheimers disease, fatty liver disease, arthritis, pain relief and even certain types of cancer

Secondly, they suppress the secretion of glucagon, a hormone produced by the alpha cells of the pancreas that raises blood sugar levels

Serious kidney problems (acute kidney injury)

doi: 10.1007/s12020-014-0386-8

Short-acting GLP-1RAs like exenatide and lixisenatide are associated with transient (112 h) increases, causing a maximum heart rate increase of 810 beats per minute (bpm) 24 h after injection, which returned to baseline after approximately 1012 h, with a mean 24 h heart rate increase of approximately 12 bpm for both GLP-1RAs in healthy adults ( Linnebjerg et al

Despite declining sharply among lookalike respondents, emotional well-being improved among current GLP-1 users this month